Lv1
40 积分 2026-02-07 加入
Tofacitinib Treatment for Pretibial Myxedema
1个月前
已完结
Efficacy and Safety of Teprotumumab in Thyroid Eye Disease: A Systematic Review and Meta-Analysis
2个月前
已关闭
Antigen presentation by human dermal fibroblasts: activation of resting T lymphocytes
2个月前
已完结
Thyroid-Stimulating Hormone Receptor Autoimmunity and Local Factors in Multiple Risk Factors Are Mainly Involved in the Occurrence of Pretibial Myxedema
2个月前
已关闭
Pretibial Myxedema as the Presenting Manifestation of Graves Disease
2个月前
已完结
Update on pathophysiology and treatment of pretibial myxedema: A comprehensive review of the literature
2个月前
已关闭
Analysis of Fibroblast-Stimulating Activity in IgG from Patients with Graves' Dermopathy
2个月前
已完结
Refractory pretibial myxoedema with response to intralesional insulin‐like growth factor 1 antagonist (octreotide): downregulation of hyaluronic acid production by the lesional fibroblasts
2个月前
已完结
34839 Game-changer or flop: Teprotumumab may not provide lasting improvement of pretibial myxedema
2个月前
已关闭
Thyroid dermopathy and acropachy
2个月前
已完结
皖公网安备34019202002308
